Isoliquiritigenin ameliorates Parkinson’s disease via gut microbiota remodeling: potential mediating role of Parabacteroides distasonis
ISL alleviates PD-related pathology partly through gut microbiota remodeling, with P. distasonis as a potential mediator.
Authors
- Maochao Zheng (ORCID: https://orcid.org/0000-0002-5505-7034)
- Junjie Xiang (ORCID: https://orcid.org/0000-0002-9698-1039)
- Mengyun Li (ORCID: https://orcid.org/0000-0001-8422-9061)
- Sheng Yang (ORCID: https://orcid.org/0000-0003-1630-8037)
- Jie Wu (ORCID: https://orcid.org/0000-0002-8880-2520)
- Jiafeng Lu
- Xiao‐Bing Zhang (ORCID: https://orcid.org/0000-0003-4319-6181)
- Lingyan He
- Xian Shao (ORCID: https://orcid.org/0000-0002-4301-0255)
Institutions
- Zhejiang Chinese Medical University (CN)
- Shaoxing University (CN)
- Shaoxing No.6 People's Hospital (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1186/s12967-025-07435-w
- Citations
- 1
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.81